We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBlackRock Smaller Companies Trust PLC Regulatory News (BRSC)

Share Price Information for BlackRock Smaller Companies Trust PLC (BRSC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,388.00
Bid: 1,384.00
Ask: 1,390.00
Change: -12.00 (-0.86%)
Spread: 6.00 (0.434%)
Open: 1,408.00
High: 1,412.00
Low: 1,384.00
Prev. Close: 1,400.00
BRSC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Portfolio Update

19 Oct 2020 17:55

BlackRock Smaller Companies Trust Plc - Portfolio Update

BlackRock Smaller Companies Trust Plc - Portfolio Update

PR Newswire

London, October 19

The information contained in this release was correct as at 30 September 2020. Information on the Company’s up to date net asset values can be found on the London Stock Exchange Website at

https://www.londonstockexchange.com/exchange/news/market-news/market-news-home.html.

BLACKROCK SMALLER COMPANIES TRUST PLC (LEI:549300MS535KC2WH4082) 

All information is at 30 September 2020 and unaudited.Performance at month end is calculated on a capital only basis 

One month %Three months %One year %Three years %Five years %
Net asset value*-2.72.2-5.4-2.237.7
Share price*-0.8-4.4-11.6-1.938.8
Numis ex Inv Companies + AIM Index-1.27.1-4.6-13.79.0

*performance calculations based on a capital only NAV with debt at par, without income reinvested. Share price performance calculations exclude income reinvestment.Sources: BlackRock and Datastream

At month end

Net asset value Capital only (debt at par value):1,392.76p
Net asset value Capital only (debt at fair value):1,373.83p
Net asset value incl. Income (debt at par value)1:1,397.58p
Net asset value incl. Income (debt at fair value)1:1,378.64p
Share price:1,220.00p
Discount to Cum Income NAV (debt at par value):12.7%
Discount to Cum Income NAV (debt at fair value):11.5%
Net yield4:2.7%
Gross assets2:£752.0m
Gearing range as a % of net assets:0-15%
Net gearing including income (debt at par):5.4%
Ongoing charges ratio (actual)3:0.7%
Ordinary shares in issue5:48,829,792

Includes net revenue of 4.82p

Yield calculations are based on dividends announced in the last 12 months as at the date of release of this announcement, and comprise the first interim dividend of 12.8 pence per share (announced on 5 November 2019, ex-dividend on 14 November 2019) and the second interim dividend of 19.7 pence per share (announced on 3 June 2020, ex-dividend on 11 June 2020).

Includes current year revenue.

As reported in the Annual Financial Report for the year ended 28 February 2019 the Ongoing Charges Ratio (OCR) was 0.7%. The OCR is calculated as a percentage of net assets and using operating expenses, excluding performance fees, finance costs and taxation.

Excludes 1,163,731 ordinary shares held in treasury.

Sector Weightings% of portfolio
Industrials27.2
Financials20.3
Consumer Services15.7
Consumer Goods11.4
Technology10.3
Health Care6.1
Basic Materials5.0
Oil & Gas1.6
Telecommunications1.3
Materials1.1
-----
Total100.0
=====
Country Weightings% of portfolio
United Kingdom98.0
United States1.0
Singapore0.6
France0.4
-----
Total100.0
=====

Ten Largest Equity Investments
Company% of portfolio
YouGov2.5
Pets at Home2.1
Avon Rubber2.0
Watches of Switzerland2.0
Games Workshop1.9
IntegraFin1.9
Impax Asset Management1.9
Ergomed1.8
Breedon1.8
Treatt1.7

Commenting on the markets, Roland Arnold, representing the Investment Manager noted:During September the Company’s NAV per share fell by -2.7%1 to 1,392.76p, underperforming our benchmark index which fell -1.2%1; for comparison the FTSE 100 Index fell by -1.6%1 (all calculations are without income reinvested).

Equity markets fell in September on the back of rising geopolitical risks and concerns over a second wave of COVID-19, with infections in several countries (most notably in Europe) rising during the month. As seen in many other countries, tighter restrictions were once again imposed in the UK to curb the spread of the virus. These included the ‘rule of six’ and reduced operating hours for the already fragile hospitality sector. Brexit made headlines with the Government’s controversial Internal Markets Bill which provoked an intense row with the EU. As a result, concerns of a “no-deal Brexit” once again came to the fore and this coupled with softer domestic data led to sterling weakness.

During the month the portfolio benefited from a number of positive updates from key holdings; however, weakness in some of our more domestically focussed holdings detracted from performance. In addition, a number of recent strong performers gave back some of their recent gains; a combination of these factors resulted in the Company’s NAV per share underperforming the benchmark. Relative performance was also impacted by not owning William Hill, the largest position in our benchmark, which received a bid from the US company Caesar’s Entertainment. This impacted relative performance by -47 basis points (and represented the single largest detractor in the month). Having performed well since providing a positive trading update in July, shares in YouGov gave back some of this recent strong performance despite there being no change to the outlook for the business. Shares in The Pebble Group fell in response to mixed results which highlighted the strength in the promotional services Facilisgroup business, while Brand Addition remained challenged during the first half of the year. Elsewhere our pub stocks, JD Wetherspoons and Youngs, were impacted by the increased restrictions imposed by the Government.

The largest positive contributor was Pets at Home, which performed well after issuing a positive trading update which highlighted strong sales momentum ahead of expectations, as customer shopping habits saw a return to normal in addition to the reinstatement of services and procedures within the veterinary and retail operations. The company said it had delivered double-digit like-for-like sales growth in the second quarter and now expect full year profits to be ahead of market expectations. Shares in Ergomed rose in response to strong interim results which showed continued revenue growth of 14.8%, with the order book up 22% since the beginning of the year, providing high visibility into the second half and beyond. Shares in Games Workshop once again contributed positively to performance. The tabletop game manufacturer reported trading which continues to be ahead of expectations, driven by growth in its online channel, with retail stores also recovering since reopening. Whilst the long-term and ongoing impact of the pandemic remains unclear, the board declared its dividend payment, in line with the company’s policy to distribute surplus cash.

The current environment continues to present a number of challenges as the outlook remains highly uncertain and investors are inconsistent on how they are pricing coronavirus risks. The smaller end of the market remains very narrow and, in our opinion, continues to inconsistently value risk. This can be seen in valuations of the winners which have continued to stretch, while the losers compress. This has also been evident in a number of cases where share prices have become completely detached from fundamentals, and we can point to a number of examples where investment cases are playing out, but the share price is telling a different story; and this disconnect certainly cannot last forever. We must all remind ourselves that in the short-term share prices are driven by supply and demand (investor sentiment), however, in the long-term it is company earnings that will drive share prices.

We therefore remain confident in our strategy on a medium-term view. Market volatility presents us with a fantastic investment opportunity. The Company’s investment strategy is focussed on quality growth investments in smaller companies, a style that has demonstrably worked for the long-term, and historically periods of sudden underperformance, such as this, have proven to be excellent investment opportunities.

1Source: BlackRock as at 30 September 2020

19 October 2020

ENDS 

Latest information is available by typing www.blackrock.co.uk/brsc on the internet, "BLRKINDEX" on Reuters, "BLRK" on Bloomberg or "8800" on Topic 3 (ICV terminal). Neither the contents of the Manager’s website nor the contents of any website accessible from hyperlinks on the Manager’s website (or any other website) is incorporated into, or forms part of, this announcement.

Date   Source Headline
25th Apr 20245:19 pmPRNHolding(s) in Company
25th Apr 202412:15 pmPRNNet Asset Value(s)
24th Apr 202412:15 pmPRNNet Asset Value(s)
23rd Apr 202412:13 pmPRNNet Asset Value(s)
22nd Apr 202411:54 amPRNNet Asset Value(s)
19th Apr 202412:07 pmPRNNet Asset Value(s)
18th Apr 202412:17 pmPRNNet Asset Value(s)
18th Apr 20247:00 amPRNTotal Voting Rights
17th Apr 202412:14 pmPRNNet Asset Value(s)
17th Apr 20247:00 amPRNTotal Voting Rights
16th Apr 20245:40 pmPRNTransaction in Own Shares
16th Apr 202412:02 pmPRNNet Asset Value(s)
16th Apr 20247:00 amPRNTotal Voting Rights
15th Apr 20245:53 pmPRNTransaction in Own Shares
15th Apr 202411:38 amPRNNet Asset Value(s)
12th Apr 20246:52 pmPRNTransaction in Own Shares
12th Apr 202412:15 pmPRNNet Asset Value(s)
11th Apr 202412:43 pmPRNHolding(s) in Company
11th Apr 202412:12 pmPRNNet Asset Value(s)
11th Apr 20247:00 amPRNTotal Voting Rights
10th Apr 202412:07 pmPRNNet Asset Value(s)
10th Apr 20247:00 amPRNTotal Voting Rights
9th Apr 20245:47 pmPRNTransaction in Own Shares
9th Apr 202411:45 amPRNNet Asset Value(s)
9th Apr 20247:00 amPRNTotal Voting Rights
8th Apr 20245:59 pmPRNTransaction in Own Shares
8th Apr 202412:00 pmPRNNet Asset Value(s)
8th Apr 20247:00 amPRNTotal Voting Rights
5th Apr 20245:45 pmPRNTransaction in Own Shares
5th Apr 202412:15 pmPRNNet Asset Value(s)
5th Apr 20247:00 amPRNTotal Voting Rights
4th Apr 20245:46 pmPRNTransaction in Own Shares
4th Apr 202412:03 pmPRNNet Asset Value(s)
4th Apr 20247:00 amPRNTotal Voting Rights
3rd Apr 20245:34 pmPRNTransaction in Own Shares
3rd Apr 202412:08 pmPRNNet Asset Value(s)
3rd Apr 20247:00 amPRNTotal Voting Rights
3rd Apr 20247:00 amPRNTransaction in Own Shares
2nd Apr 20241:00 pmPRNMandatory Closed Period Compliance with MAR
2nd Apr 202412:08 pmPRNNet Asset Value(s)
2nd Apr 20247:00 amPRNTotal Voting Rights
28th Mar 20246:22 pmPRNTransaction in Own Shares
28th Mar 202411:45 amPRNNet Asset Value(s)
28th Mar 20247:00 amPRNTotal Voting Rights
27th Mar 20245:49 pmPRNTransaction in Own Shares
27th Mar 20244:03 pmPRNPortfolio Update
27th Mar 202412:13 pmPRNNet Asset Value(s)
27th Mar 20247:00 amPRNTotal Voting Rights
26th Mar 20246:39 pmPRNTransaction in Own Shares
26th Mar 202412:04 pmPRNNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.